As micro filter, which removes particles when injecting medicine and blocks air inflow, has a structural problem in supply and demand in the global market, needs to be reverted when priming, and air inflow due to siphoning phenomenon, Meinntech developed patented technology, applied for patent, and have successfully completed product development with mold development.

If it is certified by the testing institute, it will solve the structural shortage problem in domestic and overseas markets and solve the structural problem of existing products. We are looking at going into the overseas market of 10 million dollars scale.

Anyfusion is very first product in the world, and requires clinical validation, reference, and evidence. In Korea, while trying to solve the calculation problem of HIRA, there have been many trials on developing many alternative products from inside and outside of country to replace existing products that have not been developed yet. However, Meinntech have successfully developed micro filter, and they have already been calculated separately from the HIRA, and they are commercialized in the market; thus they can be marketed once registered.

Thanks for your cooperation to all the stakeholders who contributed on product development.